

浏览全部资源
扫码关注微信
河南省中医院,郑州 450002
Received:17 March 2020,
Published Online:24 July 2020,
Published:20 November 2020
移动端阅览
王勤俭,李泊泊,董良杰等.除湿虎潜丸加减联合髓芯减压术治疗Ⅰ,Ⅱ股骨头坏死湿热痹阻证的临床观察[J].中国实验方剂学杂志,2020,26(22):71-76.
WANG Qin-jian,LI Bo-bo,DONG Liang-jie,et al.Clinical Efficacy of Modified Chushi Huqianwan Combined with Core Decompression on Ⅰ, Ⅱ Stage Osteonecrosis of Femoral Head Due to Hot and Humid Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(22):71-76.
王勤俭,李泊泊,董良杰等.除湿虎潜丸加减联合髓芯减压术治疗Ⅰ,Ⅱ股骨头坏死湿热痹阻证的临床观察[J].中国实验方剂学杂志,2020,26(22):71-76. DOI: 10.13422/j.cnki.syfjx.20201980.
WANG Qin-jian,LI Bo-bo,DONG Liang-jie,et al.Clinical Efficacy of Modified Chushi Huqianwan Combined with Core Decompression on Ⅰ, Ⅱ Stage Osteonecrosis of Femoral Head Due to Hot and Humid Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(22):71-76. DOI: 10.13422/j.cnki.syfjx.20201980.
目的
2
观察除湿虎潜丸加减联合髓芯减压术治疗Ⅰ,Ⅱ股骨头坏死湿热痹阻证的疗效及其对骨代谢指标[骨钙素(BGP),骨形态发生蛋白-2(BMP-2),骨特异性碱性磷酸酶(BALP)],血脂[载脂蛋白A(ApoA),载脂蛋白B(ApoB),载脂蛋白C3(ApoC3)],蛋白表达[基质金属蛋白酶-2(MMP-2),基质金属蛋白酶-9(MMP-9),基质金属蛋白酶组织抑制剂-2(TIMP-2)]的影响。
方法
2
90例患者被随机分为对照组和观察组,各45例。对照组给予髓芯减压术+仙灵骨葆,观察组给予髓芯减压术+除湿虎潜丸加减,疗程均为6个月。分别观察两组髋关节功能量表(HHS),外缘股骨头指数(LHI),中医证状;检测骨代谢指标(BGP,BMP-2,BALP)水平,血脂(ApoA,ApoB,ApoC3)水平,蛋白表达(MMP-2,MMP-9,TIMP-2)水平;比较两组临床疗效、不良反应和随访36个月复发情况。
结果
2
观察组总有效率97.73%(43/44),高于对照组的80.95%(34/42)(
χ
2
=5.915,
P
<
0.05);随访36个月,观察组复发率4.65%(2/43),低于对照组的35.29%(12/34)(
χ
2
=5.317,
P
<
0.05);观察组治疗后HHS,LHI较对照组明显升高(
P
<
0.05),中医证状评分较对照组明显降低(
P
<
0.05);治疗后与对照组比较,观察组BGP,BMP-2,BALP,MMP-2,MMP-9水平明显升高(
P
<
0.05),ApoA,ApoB,ApoC3,TIMP-2水平明显降低(
P
<
0.05);治疗期间未见明显不良反应。
结论
2
除湿虎潜丸加减联合髓芯减压术可明显改善Ⅰ,Ⅱ股骨头坏死湿热痹阻证患者的临床症状,骨代谢指标,血脂和蛋白表达水平。
Objective
2
To observe the efficacy of modified Chushi Huqianwan combined with core decompression on Ⅰ, Ⅱ stage osteonecrosis of femoral head due to hot and humid syndrome, and the effect on bone metabolism index [osteocalcin (BGP), bone morphogenetic protein-2 (BMP-2), bone isoenzyme alkaline phosphatase (BALP)], blood lipid [apolipoprotein A (ApoA), apolipoprotein B (ApoB), apolipoprotein C3 (ApoC3)], protein expression [matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), tissue inhibitor of matrix metalloproteinase-2 (TIMP-2)].
Method
2
A total of 90 cases were divided into control group and observation group, with 45 cases in each group. The control group was given core decompression + Xianling Gubao, while the observation group was given core decompression + modified Chushi Huqianwan for 6 months. The hip harris score (HHS), lateral head index (LHI) and traditional Chinese medicine (TCM) syndrome were observed between two groups. The serum bone metabolic indices (BGP, BMP-2, BALP), blood lipid (ApoA, ApoB, ApoC3), protein expressions (MMP-2, MMP-9, TIMP-2) were detected between two groups. The clinical efficacy, adverse reaction and recurrence in 36-month follow-up were compared between two groups.
Result
2
The total effective rate was 97.73% (43/44) in observation group, which was higher than 80.95% (34/42) in control group (
χ
2
=5.915,
P
<
0.05). The recurrence rate was 4.65% (2/43) in observation group, which was lower than 35.29% (12/34) in control group (
χ
2
=5.317,
P
<
0.05) during the 36-month follow-up. HHS and LHI in observation group were significantly higher than those in control group (
P
<
0.05), and TCM syndrome score was significantly lower than that in control group (
P
<
0.05). Compared with control group after treatment, BGP, BMP-2, BALP, MMP-2 and MMP-9 in observation group were significantly increased (
P
<
0.05), whereas ApoA, ApoB, ApoC3, TIMP-2 were significantly decreased (
P
<
0.05). No obvious adverse reactions were observed during the treatment.
Conclusion
2
Modified Chushi Huqianwan combined with core decompression can significantly improve clinical symptoms, bone metabolism indexes, blood lipid and protein expressions of patients with Ⅰ, Ⅱ stage osteonecrosis of femoral head due to hot and humid syndrome.
WANG Q R , YANG Z Y , KANG P D , et al . Femoral head and neck fenestration through a direct anterior approach combined with compacted autograft for the treatment of early stage nontraumatic osteonecrosis of the femoral head: a retrospective study [J]. J Arthroplasty , 2020 , 35 ( 3 ): 652 - 660 .
MIN B W , CHO C H , SON E S , et al . Highly cross-linked polyethylene in total hip arthroplasty in patients younger than 50 years with osteonecrosis of the femoral head: a minimum of 10 years of follow-up [J]. J Arthroplasty , 2020 , 35 ( 3 ): 805 - 810 .
DAS S H , NANDHIMANDALAM B . Letter to the editor regarding early diagnosis and treatment of steroid-induced osteonecrosis of the femoral head [J]. Int Orthop , 2020 , 44 ( 8 ): 411 - 412 .
PARK C W , LIM S J , KIM J H , et al . Hip resurfacing arthroplasty for osteonecrosis of the femoral head: implant-specific outcomes and risk factors for failure [J]. J Orthop Translat , 2020 , 21 ( 13 ): 41 - 48 .
ZHANG F , PENG W X , ZHANG J , et al . P53 and parkin co-regulate mitophagy in bone marrow mesenchymal stem cells to promote the repair of early steroid-induced osteonecrosis of the femoral head [J]. Cell Death Dis , 2020 , 11 ( 1 ): 42 - 43 .
中华老年骨科与康复电子杂志编辑委员会 . 股骨头坏死保髋治疗指南(2016 版) [J]. 中华老年骨科与康复电子杂志 , 2016 , 2 ( 2 ): 65 - 67 .
CHUGHTAI M , KELLY J J , NEWMAN J M , et al . The role of virtual rehabilitation in total and unicompartmental knee arthroplasty [J]. J Knee Surg , 2019 , 32 ( 1 ): 105 - 110 .
李泰贤 , 张彦琼 , 黄泽青 , 等 . 从分子网络解析非创伤性股骨头坏死不同中医证候的生物学基础及其对证方药的作用机制 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 16 ): 192 - 204 .
于潼 , 谢利民 , 张振南 . 成人非创伤性股骨头坏死中医证候与中医体质关系研究 [J]. 中华中医药杂志 , 2016 , 31 ( 1 ): 339 - 341 .
李泰贤 , 陈志伟 , 薛志鹏 , 等 . 中老年股骨头坏死患者中医证候特点 [J]. 中华中医药杂志 , 2019 , 34 ( 4 ): 1414 - 1418 .
刘勖 . 临床试验设计与数据处理(四) [J]. 疑难病杂志 , 2003 , 2 ( 1 ): 55 - 57
ZHAO D W , ZHANG F , WANG B J , et al . Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version) [J]. J Orthop Translat , 2020 , 6 ( 2 ): 55 - 59 .
陈卫衡 , 何伟 , 童培建 , 等 . 股骨头坏死中医辨证标准(2019年版) [J]. 中医正骨 , 2019 , 31 ( 6 ): 1 - 2 .
JWM G . ARCO committee on terminology and staging (report on the committee meeting at santiago de compostela) [J]. ARCO Newslet , 1993 , 5 ( 2 ): 79 - 82 .
刘德淮 , 陈前芬 , 陈源 , 等 . 髓芯减压植骨术治疗早、中期股骨头缺血性坏死的远期疗效 [J]. 中国修复重建外科杂志 , 2012 , 26 ( 10 ): 1165 - 1168 .
HARRIS W H . Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty: an endresult study using a new method of result evaluation [J]. J Bone Joint Surg Am , 1969 , 51 ( 4 ): 737 - 755 .
国家中医药管理局 . 中医病证诊断疗效标准 [M]. 南京 : 南京大学出版社 , 1995 : 297 - 299 .
MONT M A , CHERIAN J J , SIERRA R J , et al . Nontraumatic osteonecrosis of the femoral head: where do we stand today? A ten-year update [J]. J Bone Joint Surg Am , 2015 , 97 ( 19 ): 1604 - 1627 .
ATILLA B , BAKIOGLU S , SHOPE A J , et al . Joint-preserving procedures for osteonecrosis of the femoral head [J]. Efort Open Rev , 2019 , 4 ( 12 ): 647 - 658 .
于金高 , 刘培 , 段金廒 . 药用蜈蚣生物活性物质与毒性物质研究进展 [J]. 中国现代中药 , 2016 , 18 ( 11 ): 1521 - 1527,1536 .
刘珊珊 , 郭杰 , 李宗艾 , 等 . 泽泻化学成分及药理作用研究进展 [J]. 中国中药杂志 , 2020 , 45 ( 7 ): 1578 - 1595 .
LI J F , SHANG G W , WANG Y S , et al . Therapeutic effects of calcitonin gene-related peptide-modified bone marrow mesenchymal stem cells combined with autogenous bone grafting for treatment of osteonecrosis of the femoral head in rabbits [J]. Biochem Eng J , 2020 , 153 ( 26 ): 153 - 162 .
PARSA A , VAHEDI H , GOSWAMI K , et al . Available findings fail to provide strong evidence of the role of bone morphogenic protein-2 in femoral head osteonecrosis [J]. Arch Bone Jt Surg , 2020 , 8 ( 1 ): 5 - 10 .
TIAN Y , AN F M , WANG J Q , et al . MMP2 and MMP10 polymorphisms are related to steroid-induced osteonecrosis of the femoral head among Chinese han population [J]. Biomed Res Int , 2019 , 20 ( 13 ): 829 - 831 .
OUYANG X , DING Y Z , YU L , et al . Effects of hip replacement combined with alendronate sodium on postoperative healing of osteoporotic femoral neck fracture and levels of CTX-1 and BALP in patients [J]. Exp Ther Med , 2019 , 18 ( 6 ): 4583 - 4590 .
WANG Y , CAO Y J , LI Y Z , et al . Genetic association of the ApoB and ApoA1 gene polymorphisms with the risk for alcohol-induced osteonecrosis of femoral head [J]. Int J Clin Expe Pathol , 2015 , 8 ( 9 ): 11332 - 11339 .
HIRATA T , FUJIOKA M , TAKAHASHI K A , et al . ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation [J]. J Orthop Sci , 2007 , 12 ( 3 ): 199 - 206 .
侯鹏高 . 载脂蛋白C3研究进展 [J]. 齐齐哈尔医学院学报 , 2015 , 36 ( 8 ): 1189 - 1190 .
杨雪娜 , 熊咏民 . 基质金属蛋白酶在骨关节疾病中的研究进展 [J]. 国外医学:医学地理分册 , 2019 , 40 ( 4 ): 470 - 474 .
0
Views
14
下载量
1
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621